Famotidine Dosage for GERD in Adults
For adult patients with GERD, famotidine should be dosed at 20 mg twice daily for symptomatic non-erosive GERD, or 20-40 mg twice daily for erosive esophagitis, taken for up to 6-12 weeks depending on disease severity. 1
Standard Dosing Regimens
Non-Erosive GERD (Symptomatic)
- 20 mg twice daily for up to 6 weeks is the FDA-approved regimen for symptomatic non-erosive GERD 1
- This twice-daily dosing is necessary because famotidine's acid-inhibiting effects last approximately 6 hours 2
- Clinical studies demonstrate that 70% of patients achieve complete daytime heartburn relief and 75% achieve complete nighttime relief with this regimen 3
Erosive Esophagitis
- 20 mg twice daily OR 40 mg twice daily for up to 12 weeks, with both regimens showing effectiveness in clinical trials 1
- The higher dose (40 mg twice daily) may be considered for more severe erosive disease 1
- Famotidine has demonstrated healing rates comparable to or superior to other H2-receptor antagonists in erosive esophagitis 4, 5
Important Clinical Considerations
Timing of Administration
- Famotidine reaches peak plasma concentrations 2.5 hours after dosing, with gastric pH beginning to increase within 30 minutes 2
- The twice-daily dosing schedule is essential for maintaining adequate acid suppression throughout the day 4
Limitations of H2-Receptor Antagonists
- Tachyphylaxis develops within 6 weeks of treatment, limiting long-term effectiveness 2
- H2-receptor antagonists are less effective than PPIs for both symptom relief and healing rates of erosive esophagitis 2
- PPIs should be considered first-line therapy for most GERD patients, with H2-receptor antagonists reserved for adjunctive use (e.g., nighttime symptoms despite PPI therapy) 2
Renal Impairment Adjustments
- For creatinine clearance 30-60 mL/min: 20 mg once daily or 40 mg every other day 1
- For creatinine clearance <30 mL/min: 20 mg every other day 1
Common Pitfalls to Avoid
- Do not use famotidine as monotherapy for long-term GERD management due to rapid tachyphylaxis development 2
- Do not routinely combine famotidine with twice-daily PPI therapy, as this combination lacks evidence-based support for routine GERD management 2
- Consider famotidine primarily for breakthrough nocturnal symptoms in patients already on PPI therapy, rather than as primary treatment 2
- Famotidine is generally well-tolerated and lacks the antiandrogenic effects and drug metabolism interactions seen with cimetidine 5